Venice, Italy, 10th October 2017 / Sciad Newswire / Double Helix Technologies (Doulix) announced today a collaboration with A
Medical Technology
Tue, 10/10/2017 - 07:30
Thu, 28/09/2017 - 08:30
London, UK, 28th September 2017 / Sciad Newswire / The US approval of Novartis's Kymriah for childhood leukaemia opens a dramatic new era of cancer therapy deplo
Wed, 27/09/2017 - 07:30
Coventry, UK, 27th September 2017 / Sciad Newswire / Medherant, a leader in next-generation transdermal drug delivery, has s
Tue, 26/09/2017 - 00:15
New approach informed by government priorities, consultancy with industry and the NHS, and a century of expertise
Mon, 11/09/2017 - 07:30
Edinburgh, UK, 11th September 2017 / Synpromics Ltd, the leader in gene control and synthetic promoter development, today moves to new world-class facilities at the
Thu, 31/08/2017 - 07:30
Wed, 30/08/2017 - 15:30
London, UK, 25th August 2017 / Sciad Newswire / Touchlight Genetics Ltd has developed a revolutionary DNA technology that can synthetically manufacture commercial
Thu, 20/07/2017 - 10:59
Minomic International Ltd, an Australian immuno-oncology company, has initiated a prospective US trial of its MiCheck® prostate cancer screening test.
Mon, 26/06/2017 - 07:30
Coventry, UK, 26th June 2017 / Sciad Newswire / Medherant Ltd, a University of Warwick spin-out company developing a nex
Wed, 14/06/2017 - 07:30
Domainex Ltd. expands its partnership with Imperial College London, to discover novel therapies that reduce heart muscle damage during heart attacks.